Top Markets
Coin of the day
National Graphite Corp. National Graphite Corp.

National Graphite Corp.

NGRC
株式のランク #35948
National Graphite Corp. (NGRC), operating through its subsidiary Biotech... National Graphite Corp. (NGRC), operating through its subsidiary Biotech Development Corp., functions as a biopharmaceutical enterprise specializing in risk and cost-sharing models. The company establishes partnerships with clinical-stage firms dedicated to developing novel biological entities or innovative therapeutic platforms. These collaborations aim to address a wide spectrum of health conditions, encompassing common illnesses, rare disorders, and those with significant unmet medical requirements. Among its key pipeline developments is ELAFIN, a drug candidate identified as a human-identical protein. ELAFIN is being developed specifically for the management of postoperative inflammatory complications. The advancement of ELAFIN is further supported by a collaboration agreement with Proteo Inc. Founded in 2006, National Graphite Corp. was formerly known as Lucky Boy Silver Corporation until it officially adopted its current name in May 2012. The company maintains its operational headquarters in Duesseldorf, Germany.
株価
$0.021
最終同期: 2026-08-13
時価総額
$3.24M
変化(1日)
0.00%
変化(1年)
-46.15%
US
取引 National Graphite Corp. (NGRC)

カテゴリー

National Graphite Corp.(NGRC)の株価履歴
終値の最高値: $0.02 (2026-08-01)

終値の最安値: $13.33 (2012-08-01)
National Graphite Corp. の株価履歴(2012 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) 43.77%
2025 -40.77%
2024 -34.87%
2023 -38.75%
2022 -23.26%
2021 160.93%
2020 52.70%
2019 -17.60%
2018 -16.56%
2017 -18.16%
2016 -36.30%
2015 -74.52%
2014 -34.53%
2013 -95.88%
2012 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$300.00 0.00%
US
$2.65 0.00%
US
$22.70 0.00%
CN
$7.39 0.00%
US
$49.95 0.00%
US